12 completed, 7 terminated. 14 Phase 3, 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 7, Terminated 7 |
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow bifeprunox: new trials by email Literature Review of bifeprunox trials Research Report on bifeprunox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Bifeprunox in Patients With Schizophrenia Bifeprunox, Placebo, Quetiapine - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 346 | 2008-06-01 | 2010-09-27 |
| Efficacy of Bifeprunox in Patients With Schizophrenia Bifeprunox, Placebo, Quetiapine - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 227 | 2008-03-01 | 2010-09-27 |
| Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects bifeprunox - Healthy | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 144 | 2007-10-01 | 2009-07-10 |
| Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients Bifeprunox, Quetiapine - Schizophrenia | Phase 3 | Terminated | Solvay Pharmaceuticals | 83 | 2007-04-01 | 2008-06-04 |
| Study Evaluating Bifeprunox in Patients With Schizophrenia. Bifeprunox - Schizophrenia | Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 400 | 2007-01-01 | 2013-02-11 |
| Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint bifeprunox, risperidone - Schizophrenia | Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 400 | 2006-11-01 | 2013-02-11 |
| Open Label Extension Study of Bifeprunox Bifeprunox - Schizophrenia | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 120 | 2006-11-01 | 2007-12-27 |
| Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia. bifeprunox, olanzapine - Schizophrenia | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 120 | 2006-07-01 | 2007-12-27 |
| Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder Bifeprunox - Schizophrenia, Schizoaffective Disorder | Phase 2 | Completed | Solvay Pharmaceuticals | 2006-01-01 | 2015-01-16 | |
| Bifeprunox Extension to Extension Study in Patients With Schizophrenia Bifeprunox - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 11 | 2006-01-01 | 2013-09-16 |
| Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type bifeprunox, Placebo - Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type | Phase 3 | Terminated | Solvay Pharmaceuticals | 60 | 2005-12-01 | 2015-02-09 |
| Bifeprunox in the Treatment of Schizophrenia bifeprunox - Schizophrenia | Phase 3 | Completed | Solvay Pharmaceuticals | 986 | 2005-09-01 | 2008-03-24 |
| Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia Bifeprunox - Schizophrenia, Schizoaffective Disorder | Phase 2 | Completed | Solvay Pharmaceuticals | 2005-08-01 | 2015-01-16 | |
| Study Evaluating Bifeprunox in Bipolar Depression Bifeprunox - Depression Bipolar | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 380 | 2005-06-01 | 2007-12-05 |
| Study Evaluating Bifeprunox in Bipolar Depression Bifeprunox, Placebo - Bipolar Disorder | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 434 | 2005-06-01 | 2013-02-15 |
| Patient-reported Outcomes in the Treatment of Schizophrenia bifeprunox - Schizophrenia | Phase 3 | Completed | Solvay Pharmaceuticals | 2005-05-01 | 2013-09-12 | |
| Bifeprunox in the Treatment of Schizophrenia bifeprunox - Schizophrenia | Phase 3 | Completed | Solvay Pharmaceuticals | 2005-05-01 | 2015-01-16 | |
| To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox Bifeprunox - Schizophrenia, Schizoaffective Disorder | Phase 2 | Completed | Solvay Pharmaceuticals | 2005-05-01 | 2015-01-16 | |
| PK Effects of Bifeprunox & Valproate in Bipolar I Bifeprunox - Bipolar I Disorder | Phase 2 | Completed | Solvay Pharmaceuticals | 2005-02-01 | 2015-01-16 |
Schizophrenia (14) · Psychotic Disorders (4) · Bipolar Disorder (3) · Body Weight Changes (1) · Depression (1)
Solvay Pharmaceuticals (9) · Wyeth is now a wholly owned subsidiary of Pfizer (7) · H. Lundbeck A/S (3)
United States (12) · Czechia (2) · Estonia (2) · Poland (2) · Ukraine (2) · Argentina (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Finland (1) · Germany (1) · Greece (1) · Hungary (1) · India (1)
2005 (2)